文献速递妇科

联合血清microRNA与CA-125作为高级别浆液性卵巢癌术前手术结局的预后指标

Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-11-10

研究对56例高级别浆液性卵巢癌(HGSOC)女性和30名年龄匹配健康志愿者检测170种血清microRNA及CA-125,用逐步逻辑回归筛选预测标志物。miR-375联合CA-125区分健康与HGSOC的AUC为0.956,加入miR-210后AUC升至0.984但受溶血影响;miR-34a-5p联合CA-125预测手术完全切除的AUC为0.818。作者认为循环microRNA检测有潜力辅助规划HGSOC患者的手术管理。

要点

  • miR-375联合CA-125区分健康与HGSOC的AUC为0.956。
  • 加入miR-210后AUC升至0.984,但miR-210受溶血影响。
  • miR-34a-5p联合CA-125预测手术完全切除的AUC为0.818。

核心结论

  • 作者认为,纳入循环microRNA的分子检测有潜力预测HGSOC女性手术切除的完整性,有助于规划最佳患者管理并最终改善患者结局。

研究设计与样本

  • 研究纳入HGSOC女性(N=56)和年龄匹配健康志愿者(N=30),使用含锁核酸(LNA)引物的Serum/Plasma Focus miRNA PCR panel(Exiqon)检测170种血清microRNA,并检测同一样本的血清CA-125水平;HGSOC队列按手术结束时肉眼残留病变程度进一步分类,采用逐步逻辑回归识别预测标志物。

主要发现

  • miR-375联合CA-125是区分健康与HGSOC血清的最强判别组合,曲线下面积(AUC)为0.956。
  • 加入miR-210后AUC增至0.984,但miR-210受溶血影响。
  • miR-34a-5p联合CA-125是手术切除完整性的最强预测指标,AUC为0.818。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The most widely used approach for the clinical management of women with high-grade serous ovarian cancer (HGSOC) is surgery, followed by platinum and taxane based chemotherapy. The degree of macroscopic disease remaining at the conclusion of surgery is a key prognostic factor determining progression free and overall survival. We sought to develop a non-invasive test to assist surgeons to determine the likelihood of achieving complete surgical resection. This knowledge could be used to plan surgical approaches for optimal clinical management. METHODS: We profiled 170 serum microRNAs (miRNAs) using the Serum/Plasma Focus miRNA PCR panel containing locked nucleic acid (LNA) primers (Exiqon) in women with HGSOC (N=56) and age-matched healthy volunteers (N=30). Additionally, we measured serum CA-125 levels in the same samples. The HGSOC cohort was further classified based on the degree of macroscopic disease at the conclusion of surgery. Stepwise logistic regression was used to identify predictive markers. RESULTS: We identified a combination of miR-375 and CA-125 as the strongest discriminator of healthy versus HGSOC serum, with an area under the curve (AUC) of 0.956. The inclusion of miR-210 increased the AUC to 0.984; however, miR-210 was affected by hemolysis. The combination of miR-34a-5p and CA-125 was the strongest predictor of completeness of surgical resection with an AUC of 0.818. CONCLUSION: A molecular test incorporating circulating miRNA to predict completeness of surgical resection for women with HGSOC has the potential to contribute to planning for optimal patient management, ultimately improving patient outcome.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Shah JS, Gard GB, Yang J, et al. Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer. Gynecol Oncol. 2017. PMID: 29132874. doi:10.1016/j.ygyno.2017.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。